We will keep you informed. Here you will find our (ad-hoc-) releases for investors.
apoBank does well in spite of difficult environment
25.08.2016 - apoBank completed the first six months of 2016 with a net profit of €30.4 million, thus exceeding the level of the previous year’s period.
apoBank reorganises its rating structure
03.05.2016 - apoBank has reviewed its rating relationships with the rating agencies Moody's Investors Service and Standard and Poor's.
apoBank increases operating result
19.04.2016 - Deutsche Apotheker- und Ärztebank (apoBank) completed the 2015 financial year with an operating result of €153.4 million, considerably exceeding the previous year’s figure.
apoBank successfully placed Benchmark-Hypothekenpfandbrief
04.11.2015 - The IR release is only available in German.
apoBank continues on growth path
26.08.2015 - In the first six months of 2015, after further allocations to reserves, apoBank achieved a net profit after tax of €27.4 million, an increase on the previous year’s figure.
Moody's upgrades apoBank
22.06.2015 - Moody's upgrades apoBank on Friday 19 June 2015. The acompanying investor relations release is available in German only.
apoBank: Annual General Meeting 2015
19.06.2015 - The Annual General Meeting took place on Friday 19 June 2015. The acompanying press release is available in German only.
apoBank continues on growth path in 2014
21.04.2015 - apoBank's net profit after tax rose significantly to €54.5 million (2013: €47.4 million).
apoBank terminates Silent Participation
18.11.2014 - The IR release is only available in German.
apoBank achieves very good result in ECB Stress Test
26.10.2014 - apoBank achieves very good result in ECB Stress Test. The IR release is only available in German.
apoBank on growth path with good interim result
27.08.2014 - apoBank completed the first six months of 2014 with a net profit of €24.9 million, thus exceeding the level of the same period in the previous year.
Moody's raises apoBank’s rating by one notch to "A1"
07.05.2014 - Moody's has upgraded the rating for apoBank. The long-term debt and deposit ratings were raised by one notch from "A2" to "A1".
apoBank 2013: Good performance in challenging environment
08.04.2014 - Deutsche Apotheker- und Ärztebank (apoBank) completed financial 2013 with a net profit of €47.4 million (2012: €45.4 million).
Moody’s raises outlook for apoBank to "stable"
03.12.2013 - Due to the positive business performance of apoBank, the rating agency Moody’s today raised apoBank’s outlook from negative to stable. Its long-term A2 rating was confirmed.
apoBank terminates Silent Participation (only available in German)
19.11.2013 - This IR-Release is only available in German.
apoBank: Number of members and customer base expanded in first six months
29.08.2013 - Net profit of €24.1 million slightly above previous year’s level - Administrative expenses benefit from optimised cost structure - Implementation of customer support concept running according to plan - Outlook for 2013 confirmed: stable net profit and continuous dividend distribution planned
apoBank: Foundation for future growth laid in 2012
16.04.2013 - Deutsche Apotheker- und Ärztebank (apoBank) closed 2012 with a net profit of €45.4 million, thus exceeding the result of the previous year (2011: €43.1 million).